Product NDC: | 0641-1410 |
Proprietary Name: | Digoxin |
Non Proprietary Name: | Digoxin |
Active Ingredient(s): | .25 mg/mL & nbsp; Digoxin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-1410 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA083391 |
Marketing Category: | ANDA |
Start Marketing Date: | 19751024 |
Package NDC: | 0641-1410-35 |
Package Description: | 25 AMPULE in 1 CARTON (0641-1410-35) > 2 mL in 1 AMPULE (0641-1410-31) |
NDC Code | 0641-1410-35 |
Proprietary Name | Digoxin |
Package Description | 25 AMPULE in 1 CARTON (0641-1410-35) > 2 mL in 1 AMPULE (0641-1410-31) |
Product NDC | 0641-1410 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Digoxin |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19751024 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | DIGOXIN |
Strength Number | .25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cardiac Glycoside [EPC],Cardiac Glycosides [Chemical/Ingredient] |